78 Results
Sort By:
Published on February 6, 2017
Strata Oncology said today it will support Epizyme's ongoing Phase II clinical trial of tazemetostat in patients with relapsed or refractory non-Hodgkins lymphoma (NHL). Under the agreement the company will offer patient identification and enrollment for Epizyme’s trial through a clinical collaboration whose value was not disclosed. The collaboration is…
Published on November 3, 2016
Sifting for clues to cancer by combining genomic and clinical data is the goal of a new information platform launched today by healthcare technology developer Flatiron Health and oncology-focused molecular information company Foundation Medicine. The companies have co-developed the Clinico-Genomic Database, an information platform designed to help researchers and biopharmas speed…
Published on September 7, 2016
Researchers from the Swiss Nanoscience Institute, the University of Basel, and the University Hospital Basel have developed a new nanotechnology based method to rapidly detect genetic mutations in patients with malignant melanoma. Findings from the new study, “Fast Diagnostics of BRAF Mutations in Biopsies from Malignant Melanoma”, were published recently…